FDA Inspection
Novo Nordisk Inc.Novo Nordisk Inc. – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns Novo Nordisk Inc., with an inspection on February 7, 2025, covering drugs.
- Company
- Novo Nordisk Inc.
- Inspection Date
- February 7, 2025
- Product Type
- Drugs
View Company Profile
ID · b68c3a3c-5d39-4d5e-b050-802a21bd26f0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1255957
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
- 21 CFR 314.80(c)(2)(ii)(B)Late submission of an ICSR
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Novo Nordisk Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| December 21, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2017 | Not classified | New Jersey District Office | |
| April 13, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 22, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 12, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Novo Nordisk Inc.
- FDA Inspection 1194065 - 2022-12-21
- FDA Inspection 1018484 - 2017-06-08
- FDA Inspection 1013344 - 2017-04-13
- FDA Inspection 983531 - 2016-07-22
- FDA Inspection 968597 - 2016-04-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.